stella
beta
Tonsillectomy and Immunosuppression in Caucasian Patients With High-risk IgA-nephropathy — Stella
Home
/
Primary IgA-nephropathy
/
Tonsillectomy and Immunosuppression in Caucasian Patients With High-risk IgA-nephropathy
View on ClinicalTrials.gov
Recruiting
Back to Primary IgA-nephropathy trials
Tonsillectomy and Immunosuppression in Caucasian Patients With High-risk IgA-nephropathy
Not a traditional drug trial — this study doesn't follow the standard phase structure.
Trial locations
(2 sites)
Russia
Research Institute of Nephrology (Pavlov Medical University), Saint Petersburg
St. Petersburg State Pavlov Medical University, Saint Petersburg